Glucotrack partners with OneTwo Analytics for AI-driven clinical data analysis of implantable CBGM

Glucotrack, Inc.

Glucotrack (GCTK) enters collaboration with OneTwo Analytics AB to apply AI/ML analytics on its CBGM clinical study data.
CBGM is a long-term implantable device that measures glucose directly from blood, no external component, 3-year sensor life.
OneTwo Analytics specializes in diabetes data analytics; collaboration aims to quantify long-term benefits of CBGM.
No financial terms disclosed; agreement focuses on data analysis for clinical evaluation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.